Tufts CSDD: Adoption of AI is High Across Industry

Published on: 

Applied Clinical Trials

The Tufts Center for Drug Development found in a recent analysis that the pharmaceutical industry is adopting artificial intelligence (AI) in numerous ways. 59% of respondents said they plan to expand artificial intelligence staff through 2020. The highest  uses of AI are in clinical operations, safety/risk management, and information technology.



For more from the report, click here.